Guru Ownership Trend
Guru Analysis for Crescent Biopharma, Inc. (CBIO)
Crescent Biopharma, Inc. (CBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.61 M.
Top institutional holders include Steven Cohen and Louis Moore Bacon.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.17 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 48.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Crescent Biopharma, Inc. (CBIO)
Major holders include Steven Cohen ($5.51 M), Louis Moore Bacon ($459,250), Renaissance Technologies (RenTech) ($445,693). According to the latest reported data, 3 tracked investment managers collectively hold approximately 349,262 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.17 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CBIO. The total reported sell value was $1.17 M.
No tracked managers opened new positions or increased their holdings in CBIO during the most recent reporting period.